Gri bio to present at the h.c. wainwright 25th annual global investment conference

La jolla, ca, sept. 06, 2023 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (“nkt”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that marc hertz, phd, chief executive officer of gri bio will present at the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023 in new york, ny and virtually.
GRI Ratings Summary
GRI Quant Ranking